Published in Retina on January 01, 2010
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med (2012) 2.49
Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) (2010) 1.29
Angiogenic Factors and Cytokines in Diabetic Retinopathy. J Clin Cell Immunol (2013) 1.15
Local therapies for inflammatory eye disease in translation: past, present and future. BMC Ophthalmol (2013) 0.97
Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm (2015) 0.96
Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina. Mol Vis (2010) 0.90
More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial. Retina (2010) 0.87
Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group. Int Ophthalmol (2012) 0.84
Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol Aging (2013) 0.83
Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation. Am J Ophthalmol (2012) 0.83
Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts. J Ophthalmic Vis Res (2012) 0.81
New options for uveitis treatment. Int J Ophthalmol (2013) 0.79
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders. J Ophthalmic Inflamm Infect (2014) 0.79
Retinal function and morphology in the rabbit eye after intravitreal injection of the TNF alpha inhibitor adalimumab. Curr Eye Res (2014) 0.78
Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. Med Hypothesis Discov Innov Ophthalmol (2013) 0.77
An anti-TNF-α antibody mimetic to treat ocular inflammation. Sci Rep (2016) 0.76
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy. Int J Mol Sci (2016) 0.76
Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease. Case Rep Ophthalmol (2010) 0.75
Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy? Case Rep Ophthalmol (2016) 0.75
Management of noninfectious posterior uveitis with intravitreal drug therapy. Clin Ophthalmol (2016) 0.75
[Therapy of intermediate uveitis]. Ophthalmologe (2014) 0.75
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child. Arch Ophthalmol (2007) 1.53
Vitreoretinal surgery for optic pit associated serous macular detachment: a discussion of two cases. Int Ophthalmol (2004) 1.42
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging (2003) 1.09
Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina (2006) 0.85
Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP. Clin Cancer Res (2005) 0.84
Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. Can J Ophthalmol (2004) 0.83
Intraocular bevacizumab levels 24 hours after intravitreal injection in a normal eye. Retin Cases Brief Rep (2012) 0.82
Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis. Retina (2006) 0.81
A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy. Cancer Prev Res (Phila) (2009) 0.81
Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2006) 0.81
Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk. Adv Exp Med Biol (2008) 0.80
Choroidal neovascularization after radial optic neurotomy for central retinal vein occlusion. Retina (2004) 0.79
Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy. Retina (2013) 0.78
Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. Retina (2007) 0.77
Flat Electroretinography and Acute Visual Loss After Ocriplasmin Injection for Vitreomacular Adhesion Complicating Macular Schisis. Ophthalmic Surg Lasers Imaging Retina (2015) 0.76
Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy. Ophthalmic Surg Lasers Imaging (2003) 0.76
Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis. Hepatology (2006) 0.75